Libby P. The changing landscape of atherosclerosis. Nature. 2021;592(7855):524–33.

Article  CAS  PubMed  Google Scholar 

Shi P, Ji H, Zhang H, Yang J, Guo R, Wang J. circANRIL reduces vascular endothelial injury, oxidative stress and inflammation in rats with coronary atherosclerosis. Exp Ther Med. 2020;20(3):2245–51.

CAS  PubMed  PubMed Central  Google Scholar 

Khosravi M, Poursaleh A, Ghasempour G, Farhad S, Najafi M. The effects of oxidative stress on the development of atherosclerosis. Biol Chem. 2019;400(6):711–32.

Article  CAS  PubMed  Google Scholar 

Al-Kuraishy HM, Al-Gareeb AI, Al-Niemi MS, Aljowaie RM, Almutairi SM, Alexiou A, et al. The prospective effect of allopurinol on the oxidative stress index and endothelial dysfunction in Covid-19. Inflammation. 2022;45(4):1651–67.

Article  CAS  PubMed  Google Scholar 

Fok P-W, Lanzer P. Media sclerosis drives and localizes atherosclerosis in peripheral arteries. PLoS ONE. 2018;13(10): e0205599.

Article  PubMed  PubMed Central  Google Scholar 

Roh JW, Kwon B-J, Ihm S-H, Lim S, Park C-S, Chang K, et al. Predictors of significant coronary artery disease in patients with cerebral artery atherosclerosis. Cerebrovasc Dis. 2020;48(3–6):226–35.

Google Scholar 

Lovshin JA, Bjornstad P, Lovblom LE, Bai J-W, Lytvyn Y, Boulet G, et al. Atherosclerosis and microvascular complications: results from the Canadian study of longevity in type 1 diabetes. Diabetes Care. 2018;41(12):2570–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schipper HS, de Ferranti S. Atherosclerotic cardiovascular risk as an emerging priority in pediatrics. Pediatrics. 2022;150(5):e2022057956.

Article  PubMed  Google Scholar 

Vergallo R, Crea F. Atherosclerotic plaque healing. N Engl J Med. 2020;383(9):846–57.

Article  CAS  PubMed  Google Scholar 

Oliveira HC, Vercesi AE. Mitochondrial bioenergetics and redox dysfunctions in hypercholesterolemia and atherosclerosis. Mol Aspects Med. 2020;71: 100840.

Article  CAS  PubMed  Google Scholar 

Hartley A, Haskard D, Khamis R. Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis–novel insights and future directions in diagnosis and therapy. Trends Cardiovasc Med. 2019;29(1):22–6.

Article  CAS  PubMed  Google Scholar 

Khatana C, Saini NK, Chakrabarti S, Saini V, Sharma A, Saini RV, et al. Mechanistic insights into the oxidized low-density lipoprotein-induced atherosclerosis. Oxid Med Cell Longev. 2020;2020:5245308.

Article  PubMed  PubMed Central  Google Scholar 

Al-Kuraishy HM, Al-Gareeb AI. Effects of rosuvastatin alone or in combination with omega-3 fatty acid on adiponectin levels and cardiometabolic profile. Journal of basic and clinical pharmacy. 2016;8(1):8.

Article  PubMed  PubMed Central  Google Scholar 

Jinnouchi H, Sato Y, Sakamoto A, Cornelissen A, Mori M, Kawakami R, et al. Calcium deposition within coronary atherosclerotic lesion: Implications for plaque stability. Atherosclerosis. 2020;306:85–95.

Article  CAS  PubMed  Google Scholar 

Ito F, Ito T. High-density lipoprotein (HDL) triglyceride and oxidized HDL: new lipid biomarkers of lipoprotein-related atherosclerotic cardiovascular disease. Antioxidants. 2020;9(5):362.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gill PK, Dron JS, Hegele RA. Genetics of hypertriglyceridemia and atherosclerosis. Curr Opin Cardiol. 2021;36(3):264–71.

Article  PubMed  Google Scholar 

Hegele RA, Borén J, Ginsberg HN, Arca M, Averna M, Binder CJ, et al. Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement. Lancet Diabetes Endocrinol. 2020;8(1):50–67.

Article  CAS  PubMed  Google Scholar 

Naji MT, Sami OM, Shams HA, Abdul-Hadi MH, Al-Kuraishy HM, Al-Gareeb AI, et al. The associations between retinol binding protein-4 and cardiometabolic profile: Intertwined-intricate relationship. Biomedical and Biotechnology Research Journal (BBRJ). 2020;4(2):95–107.

Article  Google Scholar 

Jinnouchi H, Guo L, Sakamoto A, Torii S, Sato Y, Cornelissen A, et al. Diversity of macrophage phenotypes and responses in atherosclerosis. Cell Mol Life Sci. 2020;77:1919–32.

Article  CAS  PubMed  Google Scholar 

Poznyak AV, Grechko AV, Orekhova VA, Chegodaev YS, Wu W-K, Orekhov AN. Oxidative stress and antioxidants in atherosclerosis development and treatment. Biology. 2020;9(3):60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ho F, Watson AM, Elbatreek MH, Kleikers PW, Khan W, Sourris KC, et al. Endothelial reactive oxygen-forming NADPH oxidase 5 is a possible player in diabetic aortic aneurysm but not atherosclerosis. Sci Rep. 2022;12(1):11570.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pejenaute Á, Cortés A, Marqués J, Montero L, Beloqui Ó, Fortuño A, et al. NADPH oxidase overactivity underlies telomere shortening in human atherosclerosis. Int J Mol Sci. 2020;21(4):1434.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ye Z, Guo H, Wang L, Li Y, Xu M, Zhao X, et al. GALNT4 primes monocytes adhesion and transmigration by regulating O-Glycosylation of PSGL-1 in atherosclerosis. J Mol Cell Cardiol. 2022;165:54–63.

Article  CAS  PubMed  Google Scholar 

Wang C, Wang H, Zhao Z, Xiao S, Zhao Y, Duan C, et al. Pediococcus acidilactici AS185 attenuates early atherosclerosis development through inhibition of lipid regulation and inflammation in rats. J Funct Foods. 2019;60: 103424.

Article  CAS  Google Scholar 

He D, Zhao M, Wu C, Zhang W, Niu C, Yu B, et al. Apolipoprotein A-1 mimetic peptide 4F promotes endothelial repairing and compromises reendothelialization impaired by oxidized HDL through SR-B1. Redox Biol. 2018;15:228–42.

Article  CAS  PubMed  Google Scholar 

Shishikura D, Octavia Y, Hayat U, Thondapu V, Barlis P. Atherogenesis and inflammation. Interventional Cardiology: Principles and Practice. 2022:1–20. https://doi.org/10.1002/9781119697367.ch1.

Yun KH, Jeong MH, Oh SK, Lee EM, Lee J, Rhee SJ, et al. Relationship of thyroid stimulating hormone with coronary atherosclerosis in angina patients. Int J Cardiol. 2007;122(1):56–60.

Article  PubMed  Google Scholar 

Al-Naimi MS, Hussien NR, Rasheed HA, Al-Kuraishy HM, Al-Gareeb AI. Levothyroxine improves Paraoxonase (PON-1) serum levels in patients with primary hypothyroidism: Case–control study. J Adv Pharm Technol Res. 2018;9(3):113.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abdul-Hadi MH, Hussian NR, Rasheed HA, Al-Kuraishy HM, Al-Gareeb AI. Subclinical hypothyroidism and erectile dysfunction: the potential nexus. Urological Science. 2020;31(2):56.

Article  Google Scholar 

Abdulhadi MH, Al-Kuraishy HM, Al-Gareeb AI. Beneficial effects of levothyroxine replacement therapy on leptin adiponectin ratio in patients with idiopathic primary hypothyroidism. J Pak Med Assoc. 2021;71(12):S17–21.

Google Scholar 

Al-Kuraishy HM, Al-Bdulhadi MH, Al-Gareeb AI. Neuropeptide Y-Agouti related peptide ratio (NAR) in patients with idiopathic primary hypothyroidism: nudge and risk. Age (years). 2021;(12):S27–31.

Rastogi MV, LaFranchi SH. Congenital hypothyroidism. Orphanet J Rare Dis. 2010;5(1):1–22.

Article  Google Scholar 

Ragusa F, Fallahi P, Elia G, Gonnella D, Paparo SR, Giusti C, et al. Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101367.

Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015;3(4):286–95.

Article  CAS  PubMed